AKT1 and pulmonary arterial hypertension: Studies have found that pulmonary vascular remodeling was reversed, and PAH development was markedly attenuated by targeting AKT1 (Yang et al., 2021; Tang et al., 2024) or knocking out the AKT1 gene (Zuo et al., 2021).